Adenocarcinoma of the Esophagogastric Junction

Explore clinical trials studying Adenocarcinoma of the Esophagogastric Junction. Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma of the Esophagogastric Junction trial results

Not yet recruiting

Sino-Russian Comparison of Outcomes After Proximal Gastrectomy With Double-Tract Reconstruction

NCT07800819

Conditions: Adenocarcinoma of the Esophagogastric Junction, Digestive System Diseases, Duodenal Diseases, +9 more
Locations: First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China

Moscow Clinical Scientific Center named after A.S. Loginov Moscow, Russia

View Trial Details

Not yet recruiting

Intraoperative Margin Techniques for Esophagogastric Junction Adenocarcinoma: A Controlled Study

NCT07095699

Conditions: Adenocarcinoma of the Esophagogastric Junction
Locations: Not specified

View Trial Details

Active, not recruiting

A Multi-center, Two-arm, Phase 2 Clinical Study on the Perioperative Treatment of HER2-positive Resectable Esophagogastric Junctional Adenocarcinoma With Nabulimab Combined With FLOT and Trastuzumab VS FLOT Combined With Trastuzumab

NCT06681298

Conditions: Adenocarcinoma of the Esophagogastric Junction, Perioperative Period
Locations: The First Affiliated Hospital of the Air Force Medical University Xi'an, Shaanxi, China

View Trial Details

Completed

Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal Junction

NCT02287129

Conditions: Adenocarcinoma of the Esophagogastric Junction
Locations: 2nd department of the Medical Clinic of the Technical University Munich Munich, Bavaria, Germany

View Trial Details

Completed

Novel Staging Schemes for Siewert Type II Esophagogastric Junction Adenocarcinoma: A Real-World Data Cohort Study From SEER Database

NCT05419349

Conditions: Adenocarcinoma of the Esophagogastric Junction
Locations: Fujian Medical University Union Hospital Fuzhou, Fujian, China

View Trial Details

Completed

Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction

NCT00849615

Conditions: Adenocarcinoma of the Esophagogastric Junction, Digestive System Diseases, Digestive System Neoplasms, +7 more
Locations: Krankenhaus Nordwest Frankfurt, Germany

View Trial Details

Completed

Oxaliplatin and 5-Fluorouracil With or Without Docetaxel in Elderly Patients (>65 y) With Stomach and Esophagus Cancer

NCT00737373

Conditions: Adenocarcinoma of the Esophagogastric Junction, Digestive System Diseases, Digestive System Neoplasms, +7 more
Locations: Krankenhaus Nordwest Frankfurt, Germany

View Trial Details

Adenocarcinoma of the Esophagogastric Junction

Adenocarcinoma of the Esophagogastric Junction trial results

Sino-Russian Comparison of Outcomes After Proximal Gastrectomy With Double-Tract Reconstruction

Intraoperative Margin Techniques for Esophagogastric Junction Adenocarcinoma: A Controlled Study

A Multi-center, Two-arm, Phase 2 Clinical Study on the Perioperative Treatment of HER2-positive Resectable Esophagogastric Junctional Adenocarcinoma With Nabulimab Combined With FLOT and Trastuzumab VS FLOT Combined With Trastuzumab

Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal Junction

Novel Staging Schemes for Siewert Type II Esophagogastric Junction Adenocarcinoma: A Real-World Data Cohort Study From SEER Database

Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction

Oxaliplatin and 5-Fluorouracil With or Without Docetaxel in Elderly Patients (>65 y) With Stomach and Esophagus Cancer

Related conditions